Dementia Steals [0.03%]
痴呆症夺走了
Zhaohui Su
Zhaohui Su
Enhancing Perioperative Prescription Opioid Risk Mitigation Through Pharmacist Intervention [0.03%]
药师介入提升围手术期处方阿片类药物风险的管控能力
Cheyenne Barrier,Lindsay Wells,Jennifer Meyer Reid
Cheyenne Barrier
Prescription opioid risk mitigation is paramount to patient and community safety. Postoperative pain management prescriptions can lead to excess opioids in the home with many patients being unaware of proper disposal. The purpose of this in...
Optimizing Postoperative Opioid Prescribing in Veterans Undergoing Total Hip or Knee Arthroplasties [0.03%]
退伍军人髋关节或膝关节置换术后优化阿片类药物处方
Taylor Lueder,Brittany Faley,Tamara Dixon
Taylor Lueder
Opioid prescribing following orthopedic surgeries, such as total hip arthroplasties (THA) and total knee arthroplasties (TKA), is a critical focus area given the risks of dependence, adverse effects, and overprescribing. This single-center,...
Targeting Complementary Pain Pathways: The Rationale for Combining Carbamazepine and Gabapentin in Neuropathic Pain [0.03%]
靶向互补的疼痛通路：卡马西平和加巴喷丁治疗神经痛联合用药的原理
Marina Ayres Delgado,Ítala Ferreira de Jesus,Larissa Caroline Barbosa
Marina Ayres Delgado
Safety Analysis of IV Methadone vs. IV Hydromorphone in Post-Procedural Adults [0.03%]
术后成人患者静脉注射美沙酮与羟考酮的用药安全分析
Arienne Serniak,Pamela J McCormick,Marci L Pursglove et al.
Arienne Serniak et al.
IV Methadone may be used post-procedurally to manage pain; however, it carries risks of respiratory depression and QTc prolongation. The purpose of this study is to compare safety profiles of multiple doses of intravenous (IV) methadone and...
Maria Cristina Pedrazini,Thereza Cristina Pedrazini de Castilho,Victor Augusto Benedicto Dos Santos
Maria Cristina Pedrazini
Early Palliative Care Integration in End-Stage Liver Disease: A Narrative Review of Clinical Strategies for Symptom Control and Quality of Life [0.03%]
终末期肝病早期姑息治疗整合：症状控制和生活质量的临床策略叙述性综述
Daniela Sarria-Gómez,Cristhian Camilo Martínez Torres,Diana Estrada-Bermúdez et al.
Daniela Sarria-Gómez et al.
End-stage liver disease (ESLD) is associated with a high symptom burden, poor prognosis, and limited access to curative disease. Despite growing evidence supporting the role of palliative care (PC), its integration into the routine manageme...
Evaluating Methadone as Treatment for Refractory Cancer-Induced Bone Pain [0.03%]
评估美沙酮作为难治性癌症所致骨骼疼痛治疗的效果
Lindsey Dahlquist,Rebecca Peterson,Rachel Cook et al.
Lindsey Dahlquist et al.
This retrospective chart review aimed to evaluate the effectiveness of methadone for cancer-induced bone pain (CIBP) in inpatient and outpatient settings. The primary objective of this study was to analyze the change in pain scores utilizin...
Christopher Manners,Abigail Bautista,Jonathan Shammash et al.
Christopher Manners et al.
Management of chronic pain syndromes represent significant challenges to clinicians. Fluphenazine was shown to attenuate mechanical allodynia in rat neuropathic pain models via antagonism of voltage gated sodium channels and has been identi...
The Emerging Role of Ketamine and Esketamine in the Concurrent Management of Pain and Depression in Cancer Patients: Evidence and Implications for Practice [0.03%]
卡痛和艾思氯胺酮在癌症患者中并发镇痛和抑郁管理中的作用：证据与实践含义
Shannon Moriarty,Anna Dushenkov,Kathleen M Frey
Shannon Moriarty
Cancer patients frequently experience pain and depression, yet current guidelines address these conditions separately and do not recommend a single agent for concurrent management. Ketamine and its S-enantiomer esketamine, through N-methyl-...